You have no items in your shopping cart.
Teriflunomide (A-771726)
Description
Research Area
Images & Validation
−Key Properties
−| CAS Number | [163451-81-8] |
|---|---|
| MW | 270.21 |
| Formula | C12H9F3N2O2 |
| SMILES | C(NC1=CC=C(C(F)(F)F)C=C1)(=O)/C(/C#N)=C(\O)/C |
Storage & Handling
−| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Hazard Information | Non-Toxic |
| Disclaimer | For research use only |

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Protocol Information
Filter by Applications
Filter by Species
Groh, Janos et al. Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset Brain Commun, 3, (2021)
Applications
Reactivity
Hörner, Michaela et al. CNS-associated T-lymphocytes in a mouse model of Hereditary Spastic Paraplegia type 11 (SPG11) are therapeutic targets for established immunomodulators Exp Neurol, 355, 114119 (2022)
Applications
Reactivity
Groh, Janos et al. Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis Mol Ther, 25, 1889-1899 (2017)
Applications
Reactivity
